Overall [Prop (95% CI)] | Treatment [Mean (95% CI)] | Control [Mean (95% CI)] | ||||
---|---|---|---|---|---|---|
0–6 mon | 7–60 mon | 0–6 mon | 7–60 mon | 0–6 mon | 7–60 mon | |
underweight | 23.2% (21.0%, 25.0%) | 38.0% (37.3%, 38.8%) | 29.2% (26.3%, 32.3%) | 39.1% (38.2%, 40.0%) | 12.3% (9.5%, 15.5%) | 35.6% (34.2%, 36.9%) |
N | 1422 | 15,792 | 917 | 10,917 | 505 | 4875 |
wasting | 3.8% (0.8%, 10.7%) | 15.0% (14.2%, 15.8%) | 11.1% (0.3%, 48.2%) | 14.3% (13.8%, 15.6%) | 2.9% (0.3%, 9.9%) | 15.9% (14.3%, 17.7%) |
Na | 79 | 7704 | 9 | 5930 | 70 | 1774 |
stunting | 46.8% (36.4%, 57.4%) | 50.1% (49.1%, 51.1%) | 33.3% (7.5%, 70.1%) | 47.3% (46.2%, 48.4%) | 48.2% (37.3%, 59.3%) | 58.1% (56.2%, 60.0%) |
Na | 94 | 10,215 | 9 | 7572 | 85 | 2643 |